Giansun Precision Technology Group
001400
Heilongjiang Tianyouwei Electronics
603202
Joy Kie Corporation
300994
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 476.53%215.64M | -86.86%15.03M | 39.89%-62.44M | -606.94%-74.63M | -116.10%-27.9M | -135.27%-57.27M | 194.98%114.43M | 53.98%-103.89M | -123.52%-10.56M | 79.66%173.29M |
Net income from continuing operations | 10.62%67.8M | 10.33%33.97M | 45.28%-2.82M | 2.10%132.97M | -18.72%46.06M | 19.33%61.29M | 58.65%30.79M | -284.26%-5.16M | 25.71%130.24M | 67.75%56.67M |
Operating gains losses | 349.44%13.19M | -156.53%-714K | -52.55%5.68M | -75.42%3.51M | 5.83%-4.43M | -602.39%-5.29M | -87.79%1.26M | 27.33%11.96M | 160.13%14.28M | -41.64%-4.7M |
Depreciation and amortization | 2.02%15.13M | 4.22%14.86M | -1.29%14.56M | 1.79%58.33M | 0.19%14.48M | 1.95%14.83M | 0.64%14.26M | 4.42%14.75M | 9.10%57.3M | 7.79%14.46M |
Deferred tax | -354.32%-3.77M | 458.41%4.14M | -65.54%-3.98M | 85.35%-5.4M | 91.10%-3.33M | -80.54%1.48M | 69.37%-1.15M | 28.75%-2.41M | -1,391.83%-36.89M | ---37.36M |
Other non cash items | 509.71%2.76M | 243.39%9.62M | 7,720.00%391K | 120.07%1.25M | -56.32%-2M | 106.58%453K | 445.81%2.8M | -99.64%5K | -245.22%-6.25M | 22.26%-1.28M |
Change In working capital | 179.11%113.14M | -172.73%-44.82M | 35.28%-84.53M | -49.71%-302.77M | -166.71%-90.77M | -268.46%-143.01M | 137.45%61.63M | 49.49%-130.61M | -34.21%-202.23M | 395.63%136.06M |
-Change in receivables | 37.82%-67.25M | -710.07%-141.94M | 234.76%78.52M | -46.91%-109.68M | -143.32%-48.25M | -11.30%-108.16M | 114.83%23.27M | -65.52%23.46M | -222.01%-74.66M | --111.38M |
-Change in inventory | 53.55%154M | 1,920.09%113.77M | 48.53%-135.46M | -464.27%-236.24M | -258.35%-67.11M | -26.64%100.29M | -110.27%-6.25M | 6.63%-263.17M | 82.98%-41.87M | --42.38M |
-Change in payables and accrued expense | 255.48%908K | 62.20%-7.91M | -607.65%-34.13M | 135.98%29.22M | 335.67%44M | -101.55%-584K | 68.57%-20.92M | 119.97%6.72M | -165.98%-81.22M | ---18.67M |
-Change in other current assets | 75.57%11.07M | -91.34%519K | 100.71%8.51M | -107.10%-768K | -2,758.53%-17.31M | -65.40%6.3M | -30.99%6M | 125.33%4.24M | 167.67%10.82M | --651K |
-Change in other working capital | 110.23%14.42M | -115.56%-9.26M | -102.02%-1.98M | 196.09%14.71M | -780.52%-2.1M | -1,237.24%-140.87M | 656.94%59.53M | 1,649.32%98.14M | -235.30%-15.31M | --308K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 476.53%215.64M | -86.86%15.03M | 39.89%-62.44M | -606.94%-74.63M | -116.10%-27.9M | -135.27%-57.27M | 194.98%114.43M | 53.98%-103.89M | -123.52%-10.56M | 79.66%173.29M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -11.40%-15.47M | -47.27%-15.5M | -24.09%-21.88M | -19.16%-60M | -13.65%-17.96M | -28.84%-13.88M | -3.54%-10.53M | -29.57%-17.63M | 64.71%-50.35M | -21.75%-15.8M |
Net PPE purchase and sale | -11.40%-15.47M | -8.53%-15.5M | -24.09%-21.88M | -18.96%-63.76M | -13.65%-17.96M | -8.02%-13.88M | -40.50%-14.28M | -19.33%-17.63M | -33.32%-53.6M | -21.75%-15.8M |
Net business purchase and sale | --0 | ---- | ---- | 15.78%3.76M | --0 | --0 | ---- | ---- | 103.17%3.25M | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -11.40%-15.47M | -47.27%-15.5M | -24.09%-21.88M | -19.16%-60M | -13.65%-17.96M | -28.84%-13.88M | -3.54%-10.53M | -29.57%-17.63M | 64.71%-50.35M | -21.75%-15.8M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -242.83%-64.46M | 74.56%-21.47M | -4.80%130.75M | 222.67%125.68M | 116.77%27.56M | 130.93%45.13M | -181.34%-84.36M | -44.05%137.35M | 332.39%38.95M | -62.82%-164.34M |
Net issuance payments of debt | -162.54%-40.52M | 99.09%-529K | -1.02%162.14M | 78.81%223M | 137.18%52.57M | 148.41%64.78M | -145.34%-58.16M | -39.70%163.8M | 57.29%124.71M | -96.04%-141.4M |
Net common stock issuance | --0 | ---- | ---- | -37.59%-4.74M | --0 | --0 | ---- | ---- | -12.94%-3.45M | --0 |
Cash dividends paid | -1.90%-20.02M | -1.41%-19.99M | -1.35%-19.66M | -1.31%-78.4M | -1.28%-19.65M | -1.28%-19.65M | -1.39%-19.71M | -1.27%-19.4M | -1.25%-77.39M | -1.06%-19.4M |
Net other financing activities | -39,100.00%-3.92M | 45.80%-949K | -66.18%-11.73M | -187.96%-14.18M | -51.10%-5.36M | -100.14%-10K | -5.67%-1.75M | -0.28%-7.06M | 70.26%-4.92M | 45.91%-3.55M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -242.83%-64.46M | 74.56%-21.47M | -4.80%130.75M | 222.67%125.68M | 116.77%27.56M | 130.93%45.13M | -181.34%-84.36M | -44.05%137.35M | 332.39%38.95M | -62.82%-164.34M |
Net cash flow | ||||||||||
Beginning cash position | -19.63%80.12M | 26.31%101.7M | -14.06%55.59M | -26.19%64.69M | 3.95%74.1M | 53.70%99.68M | -13.02%80.52M | -26.19%64.69M | -56.87%87.65M | -32.31%71.28M |
Current changes in cash | 621.45%135.72M | -212.27%-21.94M | 193.40%46.43M | 59.21%-8.96M | -167.08%-18.29M | -554.46%-26.03M | 172.57%19.54M | 159.84%15.82M | 80.83%-21.96M | 60.76%-6.85M |
Effect of exchange rate changes | -263.23%-728K | 194.65%354K | -8,125.00%-321K | 85.90%-141K | -184.77%-217K | -36.38%446K | 52.36%-374K | 100.34%4K | 3.29%-1M | 226.11%256K |
End cash Position | 190.29%215.11M | -19.63%80.12M | 26.31%101.7M | -14.06%55.59M | -14.06%55.59M | 3.95%74.1M | 53.70%99.68M | -13.02%80.52M | -26.19%64.69M | -26.19%64.69M |
Free cash flow | 375.73%199.55M | -101.02%-1.02M | 30.08%-85.19M | -115.61%-140.65M | -129.22%-46.18M | -148.39%-72.37M | 175.57%99.76M | 49.41%-121.85M | -683.93%-65.23M | 90.22%158.05M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |